Kimiyoshi Sakaguchi

Assistant Professor

Hamamatsu Ika Daigaku

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Kimiyoshi Sakaguchi is an Assistant Professor at Hamamatsu Ika Daigaku in Japan. His research interests include pediatric oncology, focusing on childhood cancer survivorship, acute lymphoblastic leukemia, and novel therapeutic approaches. Recent publications highlight the impact of asparaginase discontinuation in treatment protocols, genetic mutations in leukemia, and the management of health and social aspects for childhood cancer survivors.

Articles (8)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2020

Year:

2020

Year:

2020

Collaborators (3)

Takao Deguchi

Head of Division

National Center For Child Health and Development

JAPAN

View details

Takashi Ishihara

Lecturer

Nara Medical University

JAPAN

View details

Hirotoshi Sakaguchi

Head

National Center For Child Health and Development

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Kimiyoshi Sakaguchi

Research Interests

Explore related searches

Contact this professor

About

Articles (8)

The parental involvement process regarding childhood cancer survivors becoming independent: Focus on balancing health management and social lives from adolescence to adulthood

RNA sequencing and target long-read sequencing reveal an intronic transposon insertion causing aberrant splicing

Impact of asparaginase discontinuation on outcomes of children with acute lymphoblastic leukaemia receiving the Japan Association of Childhood Leukaemia Study ALL‐02 protocol

Characterization of KMT2A::MATR3 fusion in a patient with acute lymphoblastic leukemia and monitoring of minimal residual disease by nanoplate digital PCR

Safety and efficacy of post-haematopoietic cell transplantation maintenance therapy with blinatumomab for relapsed/refractory CD19-positive B-cell acute lymphoblastic leukaemia: protocol for a phase I–II, multicentre, non-blinded, non-controlled trial (JPLSG SCT-ALL-BLIN21)

A case of pure erythroid leukemia with MYB–GATA1 fusion that developed tumor lysis syndrome with dexamethasone

Nationwide study of pediatric B‐cell precursor acute lymphoblastic leukemia with chromosome 8q24/MYC rearrangement in Japan

Reciprocal Regulation of HSD11B1 and HSD11B2 Predicts Glucocorticoid Sensitivity in Childhood Acute Lymphoblastic Leukemia

Collaborators (3)

Takao Deguchi

Takashi Ishihara

Hirotoshi Sakaguchi

Make your next move.